Dimethyl fumarate Teva الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).